TY - JOUR
T1 - Roles and impacts of the transplant pharmacist
T2 - A systematic review
AU - Sam, Sébastien
AU - Guérin, Aurélie
AU - Rieutord, André
AU - Belaiche, Stéphanie
AU - Bussières, Jean François
N1 - Publisher Copyright:
© 2018 Canadian Society of Hospital Pharmacists. All rights reserved.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Background: Pharmacists have been involved in the care of transplant recipients for several decades, and a growing body of literature shows the beneficial effects of clinical pharmacist care on important outcomes for these patients. Objectives: The primary objective was to describe the roles and impacts of pharmacists in a solid organ transplant setting. The secondary objective was to describe and rate the pharmacists' interventions. Data Sources: Three databases - PubMed, Embase, and Evidence-Based Medicine Reviews - were searched from January 1, 1990, to June 16, 2015. Study Selection and Data Extraction: All studies addressing the roles of pharmacists and the impacts of clinical pharmacy services on the care of solid organ transplant recipients were considered. Only studies providing a statistical analysis were included. Design, setting, sample size, patient characteristics, pharmacists' interventions, study bias, and outcomes were extracted for analysis. Data Synthesis: Four randomized controlled trials, 4 cohort studies, 3 pre-post studies, and 1 quasi-randomized controlled trial were included in the review, representing a total of 1837 patients. Of the 12 studies included, 8 specifically focused on renal transplant, and 1 each focused on liver, lung, abdominal organ, and general solid organ transplant. The pivotal pharmacist activities leading to the main patient outcomes were medication counselling (n = 8 studies), medication reconciliation (n = 5), and reviewing and optimizing drug therapy (n = 3). Improvements to medication adherence (n = 6 studies), morbidity (n = 4), costs (n = 2), and medication errors (n = 2) were reported. Conclusion: Currently available evidence suggests that pharmacists can improve patient outcomes in the solid organ transplant setting. Adherence, morbidity, costs, and medication errors were identified as the main outcomes that were improved by pharmaceutical interventions. Transplant programs need to invest more in this resource.
AB - Background: Pharmacists have been involved in the care of transplant recipients for several decades, and a growing body of literature shows the beneficial effects of clinical pharmacist care on important outcomes for these patients. Objectives: The primary objective was to describe the roles and impacts of pharmacists in a solid organ transplant setting. The secondary objective was to describe and rate the pharmacists' interventions. Data Sources: Three databases - PubMed, Embase, and Evidence-Based Medicine Reviews - were searched from January 1, 1990, to June 16, 2015. Study Selection and Data Extraction: All studies addressing the roles of pharmacists and the impacts of clinical pharmacy services on the care of solid organ transplant recipients were considered. Only studies providing a statistical analysis were included. Design, setting, sample size, patient characteristics, pharmacists' interventions, study bias, and outcomes were extracted for analysis. Data Synthesis: Four randomized controlled trials, 4 cohort studies, 3 pre-post studies, and 1 quasi-randomized controlled trial were included in the review, representing a total of 1837 patients. Of the 12 studies included, 8 specifically focused on renal transplant, and 1 each focused on liver, lung, abdominal organ, and general solid organ transplant. The pivotal pharmacist activities leading to the main patient outcomes were medication counselling (n = 8 studies), medication reconciliation (n = 5), and reviewing and optimizing drug therapy (n = 3). Improvements to medication adherence (n = 6 studies), morbidity (n = 4), costs (n = 2), and medication errors (n = 2) were reported. Conclusion: Currently available evidence suggests that pharmacists can improve patient outcomes in the solid organ transplant setting. Adherence, morbidity, costs, and medication errors were identified as the main outcomes that were improved by pharmaceutical interventions. Transplant programs need to invest more in this resource.
KW - Clinical pharmacy
KW - Impact
KW - Organ transplantation
KW - Outcome-based research
KW - Pharmacist
UR - http://www.scopus.com/inward/record.url?scp=85056120928&partnerID=8YFLogxK
U2 - 10.4212/cjhp.v71i5.2843
DO - 10.4212/cjhp.v71i5.2843
M3 - Review article
AN - SCOPUS:85056120928
SN - 0008-4123
VL - 71
SP - 324
EP - 337
JO - Canadian Journal of Hospital Pharmacy
JF - Canadian Journal of Hospital Pharmacy
IS - 5
ER -